title: Neurologic complications of HIV infection: highlights from the 2013 Conference on Retroviruses and Opportunistic Infections.
abstract: Thirty years into the HIV epidemic, the management and investigation of neurologic complications of HIV disease have evolved from a struggle to understand and treat inexorable disorders to an optimistic effort to address more subtle but often complex conditions in patients surviving long-term with a chronic disease. Although severe forms of HIV encephalitis and HIV-associated dementia, myelopathy, opportunistic infections, and neuropathy are still frequently encountered entities where access to HIV treatment is limited, in settings with sufficient resources, they are predominantly seen in those who present late to care or are unable to maintain consistent antiretroviral adherence. In 2013, practitioners, patients, and investigators can realistically aim for an outstanding quality of life for those living with HIV infection and seek to reduce morbidity associated with milder forms of HIV-associated neurocognitive disorder (HAND). Neurologic presentations at the 20th Conference on Retroviruses and Opportunistic Infections (CROI) reflected this now well-established paradigm shift, focusing on treatment strategies to optimize neurologic and cognitive function, the pathogenesis of HAND in the current era, imaging biomarkers of HAND, the confluence of HIV infection and aging, and characterization of central nervous system HIV reservoirs of infection.
authors: Yale University, New Haven, Connecticut, USA.
authors: Serena S
authors: SS
authors: Spudich
authors: Beau M
authors: BM
authors: Ances
mesh_terms: D057210:Delayed Diagnosis; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D055118:Medication Adherence; D009422:Nervous System Diseases / Q000453:epidemiology* / Q000473:pathology* / Q000517:prevention & control / Q000628:therapy
references: Neurology. 2012 Feb 14;78(7):485-92
references: 22330412
references: J Neurovirol. 2011 Feb;17(1):3-16
references: 21174240
references: AIDS. 2012 Sep 10;26(14):1765-74
references: 22614889
references: J Neuroimmunol. 2004 Dec;157(1-2):197-202
references: 15579298
references: J Infect Dis. 2010 Dec 15;202(12):1819-25
references: 21050119
references: Am J Med. 2005 Aug;118(8):890-8
references: 16084183
references: Arch Neurol. 2008 Jan;65(1):65-70
references: 18195140
references: Neurology. 2004 Sep 14;63(5):822-7
references: 15365130
references: Clin Infect Dis. 2010 Mar 1;50(5):773-8
references: 20100092
references: AIDS Behav. 2011 Aug;15(6):1187-96
references: 20865313
references: Clin Neuropsychol. 2010 Feb;24(2):265-85
references: 20162495